As medical researchers and clinicians, we are concerned about the proposed reductions in funding for the U.S. National ...

Journal of Nuclear Medicine June 2025, jnumed.125.270055; DOI: https://doi.org/10.2967/jnumed.125.270055 ...

Journal of Nuclear Medicine June 2025, jnumed.125.269655; DOI: https://doi.org/10.2967/jnumed.125.269655 ...

MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors ...

Dr. Richard Zimmermann is a distinguished figure in the field of nuclear medicine and radiopharmaceuticals. With a strong academic foundation, he holds MSc degrees in organic chemistry, physical ...

The study of the human phenome is essential for understanding the complexities of wellness and disease and their transitions, with molecular imaging being a vital tool in this exploration. Molecular ...

This review explores the role of PET in imaging immune activation, particularly in oncology. 18 F-FDG is widely used for assessing treatment response to immunotherapies and can demonstrate unique ...

EDA-FN is abundant in BC, with high EDA-FN expression associated with poor overall survival (15). Hormone receptor- and human epidermal growth factor receptor 2–negative BCs, collectively known as ...

The Highlights Lecture, presented at the closing session of each SNMMI Annual Meeting, was originated and presented for more than 30 y by Henry N. Wagner, Jr., MD. Beginning in 2010, the duties of ...

The field of nuclear medicine is going through a renaissance with significant investment by a biotechnology and pharmaceutical industry finally recognizing the benefits of the theranostic paradigm.

Prostate-specific membrane antigen (PSMA) PET is a well-established imaging tool for the evaluation of primary and recurrent prostate cancer (PCa). 177 Lu PSMA-targeted radiopharmaceutical therapy ...